Dental Practice Valuation Multiples in Ohio (2026)

Two offers land on the same Ohio general practice, and they sit $324,500 apart at the closing table. The one with the bigger multiple writes the smaller check.

That gap is the whole story of dental valuation in Ohio in 2026, and most owners never see it because they're comparing a headline number to a headline number instead of comparing cash. Here's our thesis, and plenty of brokers will fight us on it: if you own a single general practice in Ohio collecting under about $1.2 million, the DSO multiple is not your market, and organizing your exit around getting into that market will usually cost you money. You don't sell a multiple. You sell a denominator, and the buyer gets to define it.

Cleveland's 7x to 9x Is a Real Number for Practices You Don't Own

The number circulating in Ohio owner circles right now is 7x to 9x EBITDA. It's real. Dental Transitions reports that Cleveland-area practices in the $1 million to $3 million EBITDA band traded at roughly 7x to 9x EBITDA as regional DSO add-ons in 2026.

Read that band again. One million dollars of EBITDA. Not collections. Not production. Not what you take home. EBITDA, calculated after a market-rate clinical wage for every dentist in the building, after a real practice manager's salary, after rent at arm's length.

A practice generating $1 million in EBITDA is not a practice. It's a small group, usually six to twelve locations, with a regional manager, a centralized revenue cycle, and a credentialing person who does nothing else. The same Dental Transitions piece makes the contrast explicit: a $2 million-revenue practice throwing off $400,000 in EBITDA transacts with a private buyer at 65% to 85% of collections instead.

So the 7x to 9x Cleveland figure is accurate and almost entirely irrelevant to the owner reading it, which is exactly why it travels so well.

The Denominator Is the Deal, Not the Multiple

Here's where the published bands start disagreeing with each other, and the disagreement is more useful than any single number.

Deal Prospectors puts solo and small practices selling to DSOs at 5x to 7x profit, against 60% to 80% of collections if the buyer is another dentist. It stacks the rest of the market above that: small groups at 7x to 9x, mid-sized groups at 9x to 11x, large groups at 10x to 12x, and specialty practices at 10x to 14x.

CT Acquisitions reports 2026 U.S. deal data on a different basis: solo GP practices under $500,000 of SDE at 4.0x to 6.0x SDE, multi-location groups at $1.0 million to $3.0 million EBITDA at 6.5x to 9.0x, regional multi-site at $3.0 million to $10.0 million EBITDA at 8.0x to 11.0x, and platform-tier DSOs above $10 million EBITDA at 10.0x to 15.0x.

Now do the arithmetic that nobody does. Take a $1.1 million Ohio general practice where the owner is the only dentist. True seller's discretionary earnings, the number that includes everything the owner takes out, might be $407,000. At 4.0x to 6.0x, that implies $1.63 million to $2.44 million. That's 148% to 222% of collections. No bank in Ohio is underwriting that loan, and no dentist buyer is signing it.

The bands only reconcile if "SDE" in that solo tier is being measured after a market clinical wage comes out, which makes it behave like EBITDA, not like the SDE your accountant would hand you. Our view: the multiple is the least informative number in any valuation conversation, and the definition of the earnings line underneath it is the entire negotiation. When a buyer opens with a multiple before agreeing on the denominator, they're not making an offer. They're setting an anchor.

A $1.1M Practice in Akron: $770,000 vs. $445,500 at Close

Work it all the way through. Solo general practice, $1.1 million in collections, five operatories, owner is the only producer.

• Operating expenses before owner compensation, at 63%: $693,000.
• Pre-owner cash flow: $407,000.
• Associate replacement at 28% of collections, because a buyer has to pay someone to do your dentistry: $308,000.
• Adjusted EBITDA: $99,000.

Path one, the dentist buyer. At 70% of collections, the midpoint of the 65% to 85% range Dental Transitions cites for private-buyer deals, the price is $770,000. Bank-financed, cash at close, 60 to 90 days from letter of intent to funding, typically with a short transition period and no equity left behind.

Path two, the DSO. At 6x adjusted EBITDA, the middle of the 5x to 7x solo band, the enterprise value is $594,000. That's $176,000 less than the dentist buyer's number before a single term is negotiated.

Then the structure. Assume 25% of consideration rolls into holdco equity, which is standard in the add-on tier. Cash at close: $445,500. Against $770,000 all cash, the owner is $324,500 lighter on closing day.

The rollover is supposed to fix this. The pitch is that $148,500 of equity rides a second sale at a platform multiple. Assume the sponsor doubles the equity in five years. That's $148,500 of gain, which is less than the $324,500 you gave up on day one, and you waited five years and carried the risk of a recap that never comes.

We'd take the dentist buyer. Not always, not for everyone, but on this fact pattern it isn't close.

What Most Owners Get Wrong: Comparing a Gross Price to a Net Price

The specific mistake, and it's overwhelmingly made by solo owners between 55 and 65 who are two to four years from stopping, is treating the DSO's enterprise value and the dentist buyer's purchase price as the same kind of number. They are not.

The dentist buyer's $770,000 is a gross price for the business, and you walk. The DSO's $594,000 is an enterprise value that then gets reduced by rollover equity, holdbacks, escrow, and a working-capital true-up, and it comes bundled with a post-close employment agreement that pays you a percentage of your own collections for three years. That employment agreement is the part owners skim. If your associate-comp rate under the DSO is 30% of collections and you were previously clearing $407,000 on $1.1 million of personal production, you're now making $330,000 a year for the same chairside work. That's $77,000 a year of income you handed over, three years running, $231,000 total.

Add that to the $324,500 closing-day gap and the DSO path is down more than half a million dollars against a straightforward sale to a dentist, before anyone argues about whether the rolled equity is worth what the slide deck says.

The second mistake is smaller but more common: owners use their tax return's net income as the denominator. Buyers don't. Buyers rebuild the P&L with a clinical wage, a manager's salary, market rent on the building you own, and normalized supply and lab costs. Every add-back you claim is a negotiation you have to win with documents, not adjectives.

The Ten-Practice Path to 8x, and What It Actually Costs

The honest counter to all of this is that you can go get the better multiple. The bands are real, and the arbitrage between the solo tier and the group tier is genuine money. Nobody should pretend otherwise.

Price the journey. To reach the $1 million EBITDA band where Cleveland add-ons clear 7x to 9x, you need roughly ten practices like the one above, net of the regional overhead a group of that size requires. Buying nine of them at around $600,000 each is $5.4 million of acquisition debt. Sell the group at 8x on $1 million of EBITDA and you get $8 million. Net of the debt, $2.6 million.

Against $770,000 today, that looks like an easy call. It isn't. That path takes five to seven years, requires you to become a full-time operator of a multi-site business rather than a dentist, and exposes you to integration failure, a regional manager who quits, and a credit market that decides mid-build it no longer likes practice roll-ups. Our position: the roll-up is a legitimate business, and it is not an exit strategy. If you want to run a group, run a group. If you want to retire, the multiple you're chasing belongs to someone else's job.

Where the Ohio For-Sale Market Actually Sits

Scale matters here, so it's worth grounding what's actually on the market. In the Practice Market Index, our dataset built from 925 dental practice broker listings, the median listed practice collects $957,588 (middle half $650,000 to $1,500,000, n=753). General practices specifically come in at a median $946,000 (n=644). Median operatory count is 5 (n=754), and collections per operatory run a median $200,000 (n=643).

Those figures describe the asking side of the market, the practices that are currently for sale, not practices generally. But the shape is instructive: the middle of the listed market is a five-chair general practice under a million in collections. That practice does not produce $1 million of EBITDA. It doesn't produce $300,000 of EBITDA. The tier structure published by Deal Prospectors and CT Acquisitions puts it squarely in the lowest band, and the Cleveland 7x to 9x headline is describing a buyer who wants ten of these bolted together.

The demographic pressure is the one thing genuinely working in sellers' favor. Private practice ownership among U.S. dentists fell to 72.5% in 2023 from 84.7% in 2005, and 16.1% of dentists were DSO-affiliated in 2024, per the ADA Health Policy Institute. Among newer dentists the shift is sharper: DSO affiliation rose from 8.8% in 2017 to 13% in 2022 and hits 27% among dentists five or fewer years out of school, according to ADA News. Fewer young dentists want to own, which thins the private buyer pool over time. That argues for selling to a dentist sooner, not for waiting on a DSO.

Three Things to Do Before You Take a DSO Call

Rebuild your last twelve months of P&L this week with a 28% clinical wage on your own production, a market salary for whoever runs your front office, and arm's-length rent if you own the building. Whatever's left is your denominator, and it is the only number that matters when a multiple gets quoted at you. Then price the same practice at 65%, 70%, and 85% of trailing collections so you have the dentist-buyer range in hand before anyone anchors you. When the DSO call comes, ask for cash at close, rollover percentage, and the post-close compensation rate in the first ten minutes; if they won't give all three, there's nothing to evaluate.

Run the same rebuild on your own numbers with our free valuation calculator and see where your adjusted earnings actually land against the bands above. It takes about five minutes and gives you the denominator before a buyer hands you theirs. Run your own numbers.

What we're watching into 2027: whether Ohio add-on pricing holds at 7x to 9x as debt costs keep squeezing sponsor returns, and whether bank appetite for single-practice acquisition loans stays where it is. Two things would change our call. If DSOs start putting 90% or better of consideration in cash at close, the closing-day gap disappears and the rollover becomes free optionality. And if lenders pull back on dentist-buyer financing the way they did on commercial real estate, the private buyer path gets slower and thinner, and a worse multiple with certain cash starts to look like the better deal. Neither has happened yet.